• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Taglich Brothers Assigns 'Buy' Rating to Solis Tek, Sees >100% Upside

November 21, 2017

 

Taglich Brothers' John Nobile just initiated coverage and assigned a 'buy' rating on shares of Solis Tek, Inc. (OTC:SLTK) alongside a twelve-month price target of $3.00 per share. 

 

With a last trade price of $1.41 for shares of Solis Tek on the OTC markets, this price target represents over 100% potential upside. Nobile's thesis is based on a few main facts and figures including the growth of the recreational and medicinal cannabis cultivation industries.

 

Nobile wrote, "We believe that as cannabis growers expand their use of SLTK’s lighting products (including a new lighting controller product), and begin to purchase the company’s nutrient product Terpenez, the company is well positioned to capitalize on the expanding legalization of cannabis in the US and should be able to increase its market penetration through our forecast horizon."

 

For the full 18-page SLTK research report, click here

 

To be clear, all research issued by Taglich Brothers, Inc. is based on public information. Solis Tek paid a fee of $4,500 in September 2017 for the creation and dissemination of research reports for the first three months. After the first three months from initial publication, the company will pay a monthly monetary fee of $1,500 to Taglich Brothers, Inc., for a minimum of six months for the creation and dissemination of research reports.

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, YouTube, and Instagram.

 

D/M/O

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.